Literature DB >> 22618382

Angiogenesis: a harmonized target for recovery after stroke.

Adviye Ergul1, Ahmed Alhusban, Susan C Fagan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22618382      PMCID： PMC3404267          DOI： 10.1161/STROKEAHA.111.642710

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  82 in total

1.  Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype.

Authors:  Bing Zhu; Li Zhang; Mikhail Alexeyev; Diego F Alvarez; Samuel J Strada; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-21       Impact factor: 5.464

Review 2.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 3.  Diverse effects of statins on angiogenesis: new therapeutic avenues.

Authors:  Hazem F Elewa; Azza B El-Remessy; Payaningal R Somanath; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2010-02       Impact factor: 4.705

4.  Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression.

Authors:  Luye Qin; Eunhee Kim; Rajiv Ratan; Francis S Lee; Sunghee Cho
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

Review 5.  Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.

Authors:  Lauren M Willis; Azza B El-Remessy; Payaningal R Somanath; David L Deremer; Susan C Fagan
Journal:  Clin Sci (Lond)       Date:  2011-04       Impact factor: 6.124

6.  VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1.

Authors:  Samuel Valable; Joan Montaner; Anita Bellail; Vincent Berezowski; Julien Brillault; Romeo Cecchelli; Didier Divoux; Eric T Mackenzie; Myriam Bernaudin; Simon Roussel; Edwige Petit
Journal:  J Cereb Blood Flow Metab       Date:  2005-11       Impact factor: 6.200

7.  Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke.

Authors:  Anna Kozak; Adviye Ergul; Azza B El-Remessy; Maribeth H Johnson; Livia S Machado; Hazem F Elewa; Mohammed Abdelsaid; Daniel C Wiley; Susan C Fagan
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

8.  Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain.

Authors:  Abner Louissaint; Sudha Rao; Caroline Leventhal; Steven A Goldman
Journal:  Neuron       Date:  2002-06-13       Impact factor: 17.173

9.  Role of angiogenesis in patients with cerebral ischemic stroke.

Authors:  J Krupinski; J Kaluza; P Kumar; S Kumar; J M Wang
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

10.  Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke.

Authors:  Weihua Guan; Payaningal R Somanath; Anna Kozak; Anna Goc; Azza B El-Remessy; Adviye Ergul; Maribeth H Johnson; Ahmed Alhusban; Sahar Soliman; Susan C Fagan
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240
View more
  94 in total

Review 1.  Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury.

Authors:  Roshini Prakash; S Thomas Carmichael
Journal:  Curr Opin Neurol       Date:  2015-12       Impact factor: 5.710

2.  Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke.

Authors:  Ruslan Rust; Lisa Grönnert; Christina Gantner; Alinda Enzler; Geertje Mulders; Rebecca Z Weber; Arthur Siewert; Yanuar D P Limasale; Andrea Meinhardt; Michael A Maurer; Andrea M Sartori; Anna-Sophie Hofer; Carsten Werner; Martin E Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

Review 3.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

4.  Poster Viewing Sessions PA00-A01 to PA00-A49.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 5.  Motor compensation and its effects on neural reorganization after stroke.

Authors:  Theresa A Jones
Journal:  Nat Rev Neurosci       Date:  2017-03-23       Impact factor: 34.870

6.  Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke.

Authors:  Abdelrahman Y Fouda; Ahmed Alhusban; Tauheed Ishrat; Bindu Pillai; Wael Eldahshan; Jennifer L Waller; Adviye Ergul; Susan C Fagan
Journal:  Mol Neurobiol       Date:  2016-01-12       Impact factor: 5.590

Review 7.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

8.  Endogenous endothelial progenitor cells participate in neovascularization via CXCR4/SDF-1 axis and improve outcome after stroke.

Authors:  Ling Mao; Ming Huang; Sheng-Cai Chen; Ya-Nan Li; Yuan-Peng Xia; Quan-Wei He; Meng-Die Wang; Yan Huang; Long Zheng; Bo Hu
Journal:  CNS Neurosci Ther       Date:  2014-03-02       Impact factor: 5.243

Review 9.  The role of non-coding RNAs in neuroprotection and angiogenesis following ischemic stroke.

Authors:  Elaheh Heydari; Masoumeh Alishahi; Farhoodeh Ghaedrahmati; William Winlow; Seyed Esmaeil Khoshnam; Amir Anbiyaiee
Journal:  Metab Brain Dis       Date:  2019-08-24       Impact factor: 3.584

10.  Inhibition of Toll-Like Receptor-4 (TLR-4) Improves Neurobehavioral Outcomes After Acute Ischemic Stroke in Diabetic Rats: Possible Role of Vascular Endothelial TLR-4.

Authors:  Yasir Abdul; Mohammed Abdelsaid; Weiguo Li; R Clinton Webb; Jennifer C Sullivan; Guangkuo Dong; Adviye Ergul
Journal:  Mol Neurobiol       Date:  2018-06-16       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.